Aquestive Therapeutics, Inc. - AQST

SEC FilingsOur AQST Tweets

About Gravity Analytica

Recent News

  • 05.13.2025 - Q1 2025 Aquestive Therapeutics, Inc. Earnings Conference Call
  • 05.13.2025 - Q1 2025 Aquestive Therapeutics, Inc. Earnings Conference Call
  • 05.12.2025 - Aquestive Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
  • 05.12.2025 - Aquestive Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
  • 05.12.2025 - Aquestive Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
  • 05.08.2025 - Citizens Life Sciences Conference
  • 05.08.2025 - Citizens Life Sciences Conference
  • 05.05.2025 - Aquestive Therapeutics to Participate in Citizens Life Sciences Conference
  • 05.05.2025 - Aquestive Therapeutics to Participate in Citizens Life Sciences Conference
  • 05.05.2025 - Aquestive Therapeutics to Participate in Citizens Life Sciences Conference

Recent Filings

  • 05.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 05.12.2025 - 8-K Current report
  • 05.12.2025 - EX-99.1 EX-99.1
  • 05.07.2025 - 3 Initial statement of beneficial ownership of securities
  • 04.25.2025 - ARS Annual Report to Security Holders
  • 04.25.2025 - DEF 14A Other definitive proxy statements
  • 04.25.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material